Biomaterials Market for Implantable Devices Report 2014: Metals, Polymers, Ceramics and Natural Analysis
M2 - Tue Jul 22, 3:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nqrtf2/biomaterials) has announced the addition of the "Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global biomaterials market was valued at USD 25,277.8 million in 2012 and is expected to reach USD 33,600 million in 2019, growing at a CAGR of 4.1% during the forecast period 2013 to 2019 The biomaterials market has been extensively analyzed on the basis of material types, their use in various healthcare applications, success rate and geographical reach. Material type segment includes metals, polymers, ceramics and biomaterials derived from natural origin. Each material type is further segmented into various healthcare applications namely, cardiology, orthopedics, dental, ophthalmology and others which include urology, neurology and gasteroenterology. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW). Each of the segments have been analyzed on the basis of their current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players is provided in this report. The players profiled in this report include AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Ceradyne, Inc., Collagen Matrix, Inc., DuPont, Evonik Industries AG, Corbion Purac, Ulbrich Stainless Steel & Special Metals, Inc., Royal DSM and Invibio, Inc. Each of these market players are profiled in this report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Biomaterials Market for Implantable Devices, Market Overview Chapter 4 Global Biomaterials Market for Implantable Devices, by Material type Chapter 5 Global Biomaterials Market for Implantable Devices, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - AdvanSource Biomaterials Corporation - Biomet, Inc. - Celanese Corporation - Ceradyne, Inc. - Collagen Matrix, Inc. - Corbion Purac - DuPont (E. I. DU PONT DE NEMOURS AND COMPANY) - Evonik Industries AG - Invibio, Inc. - Orthofix Holdings, Inc. - Royal DSM - Ulbrich Stainless Steels & Special Metals, Inc. For more information visit http://www.researchandmarkets.com/research/nq...omaterials
Global Coatings for Medical Devices Market 2014-2020: Strategic Business Report - US Dominates Medical Device Coatings Sales
M2 - Wed May 14, 4:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/shv4d9/coatings_for) has announced the addition of the "Coatings for Medical Devices - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Coatings for Medical Devices in US$ Million by the following Product Segments: Active Coatings, Protective Coatings, Optical Coatings, and Nanotechnology Coatings. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered (Partial Table of Contents) I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS - Active Coatings - Protective Coatings - Optical Coatings - Nanotechnology Coatings II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW - Bacterial Growth & Contamination: An Ever Present Issue - Coatings - Indispensable in Medical Devices - Current and Future Analysis - US Dominates Medical Device Coatings Sales - Healthcare Economics and its Impact on Medical Device Spending - Impact of Stringent Regulations 2. MARKET TRENDS AND ISSUES - Sustained Demand for Medical Devices Augurs Well for Market Growth - Focus on Reducing Hospital Stays Lends Traction - Rising Incidence of Hospital Acquired Infections Boost Demand - Growing Awareness of Minimally Invasive Surgeries Spurs Adoption - Anti-Microbial Coatings Gain Preference Over Antibiotics - Need to Curb HAIs Spurs Demand for Anti-Microbial Coatings - Innovation Key to Market Growth - Rising Demand for Anti-Microbial Coated Catheters - Coated Urinary (Bladder) Catheters - Consumer Ignorance Acts as an Impasse for Faster Uptake - The Criticality of Choice of Anti-Microbial Ingredients - Growing Usage of Hydrophilic Surface Coatings Spurs Demand - Graphene Coatings - A High Potential Product - Silver-based Microbial Coatings Witness Strong Usage - Nanocoatings Poised to Make Rapid Gains - Nanotechnology Potential in Coatings: Yet to be Fully Explored - Nanomaterial Applications in Medical Devices - Multi-Functional Coatings: A One-for-All Approach against Device-Induced Infection - Aqueous-based Coatings Win Over Solvent-Based Coatings - Smart Coatings Still in Nascent Stages - Titanium Coatings in Structural Implants: Improving Strength & Reducing Friction - Patents on Coatings Enhance Value of Medical Devices - Innovations: Inspiring Development of Novel Coatings - Novel Nanocomposite Coatings - Pitcher Plant Inspired Transparent Coating - Coated Devices to Aid in Preventing Device Rejection by Immune System - Developing Economies Turbo Charge Market Growth 3. PRODUCT OVERVIEW - Coating for Medical Devices - Expanding Beyond Boundaries - Medical Device Coatings - Active Coatings - Optical Coatings - Protective Coatings - Nano-based Coatings - Coating and Surface Treatment Technologies - Surface Adsorption - Drug Sequestering - Ion Beam Assisted Deposition - Ion Implantation - Physical Vapor Deposition - Plasma Surface Modification - Plasma Surface Modification Technology Applications by Medical Specialty - Ultraviolet Curing - Issues Associated with Coating Technologies - Medical Device Coating Materials - Aluminum - Aluminum Fluoride - Diamond Coatings - Parylene Coating - Parylene HT - Parylene HT Applications - Silver - Silver Coating Technique - Silicone - Titanium Dioxide - TiN 4. RECENT INDUSTRY ACTIVITY - Q3 Medical Devices and Interface Biologics Ink Agreement to Develop Drug Coated Balloon - DSM Establishes Medical Coating Service Facility - Bactiguard Inks Agreement with Tecnolab Cia - Vention Medical Takes Over RiverTech Medical - BiO2 Medical and DSM Ink Partnership Agreement for Supply of ComfortCoat - Hydromer Inks License Agreements for Medical Coatings - LEUKOCARE and Xenios Partner to Develop Anti- Inflammatory Surface Coated Extracorporeal Support Systems - Innovative Surface and Surnetics Sign MOU to Formulate Microfluidic Solutions - Hydromer Inks License Agreement with Chinese Companies for Medical Coatings - Teleflex Takes Over Semprus 5. PRODUCT INNOVATIONS/INTRODUCTIONS - Boyd Develops Zero-PFOA PTFE Coating - Specialty Coating Launches Antimicrobial Parylene Coating - Europlasma Introduces Novel Nanocoatings - Medi-Solve Rolls Out AquaCoat? Technology Platform - SurModics Launches SurModics Serene Lubricious Coatings - Biocoat Unveils Novel Hydrophilic Coatings for Medical Devices 6. FOCUS ON SELECT GLOBAL PLAYERS - AdvanSource Biomaterials Corp. (US) - AeonClad Coatings (US) - Allvivo Vascular, Inc. (US) - Armoloy of Connecticut, Inc. (US) - AST Products, Inc. (US) - Biocoat, Inc. (US) - Biophan Technologies, Inc. (US) - Carmeda AB (Sweden) - Covalon Technologies Ltd. (Canada) - Royal DSM (The Netherlands) - Hemoteq AG (Germany) - Hydromer, Inc. (US) - Nanocopoeia, Inc. (US) - Specialty Coating Systems, Inc. (US) - N2 Biomedical (US) - SurModics, Inc. (US) 7. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 6. LATIN AMERICA 7. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 60 (including Divisions/Subsidiaries 61) - The United States (46) - Canada (4) - Europe (11) - - Germany (2) - - The United Kingdom (4) - - Italy (1) - - Rest of Europe (4) For more information visit http://www.researchandmarkets.com/research/sh...atings_for
Suburban Minerals Publishes New Website and Social Media Pages
Marketwire - Thu Feb 13, 7:15AM CST
Suburban Minerals Corp. (OTC Pink: SUBB) announced today the publishing of a new website, a Facebook page and a Twitter page as well.
Global Biomaterials Market 2012-2016: High R&D Costs Could Pose a Challenge to the Growth of the Market
M2 - Wed Feb 05, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/kl58bq/global) has announced the addition of the "Global Biomaterials Market 2012-2016" report to their offering. The analysts forecast the Global Biomaterials market to grow at a CAGR of 14.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Biomaterials market has also been witnessing the emergence of innovative biomaterial products. However, high R&D costs could pose a challenge to the growth of this market. The key vendors dominating this space include Biomet Inc., Evonik Industries AG, Exactech Inc., and Wright Medical Group Inc. The other vendors mentioned in this report are 3DM Inc., AdvanSource Biomaterials Corp., Allergan Inc., Alphatec Spine Inc., Amedica Corp., Angiotech Pharmaceuticals Inc., Basf SE, Bayer AG, Berkeley Advanced Biomaterials Inc., Biocomposites Ltd., BioSyntech Inc., Cam Bioceramics BV, Carpenter Technology Corp., Ceradyne Inc., Ceramtec Collagen Matrix Inc., CollPlant Holdings Ltd., Covalon Technologies Ltd., CryoLife Inc., Dentsply International Inc., Depuy Orthopaedics Inc., Dsm Biomedical Inc., ETEX Corp., Heraeus Medical Components Inc., Hycail Finland OY, Integra LifeSciences Holdings Corp., Invibio Ltd., Kyocera Corp., Landec Corp., Materion Corp., Medtronic Inc., Morgan Technical Ceramics, Orthovita Inc., Osteotech Inc., Purac Biomaterials, RTI Biologics Inc., Sigma-Aldrich Corp., Starch Medical Inc., Stryker Corp., Ticona GmbH, Ulbrich Stainless Steels & Special Metals Inc., and Zimmer Holdings Inc. Commenting on the report, an analyst from the team said: There has been steady innovation in the Global Biomaterials market with several players increasing R&D expenditure every year. For instance, the use of carbon fiber in conjunction with biomaterials for the manufacture of composite materials is being explored. While innovation is imperative in an industry such as this where competition is rampant, the need for novel solutions to cater to patient needs in the Medical industry is also expected to lead to innovation in the market. Biomaterials were traditionally used for repair and replacement of body tissues. However, there has been an increasing focus on the provision of biomaterials for self-healing in patients. Thus, the Global Biomaterials market is expected to witness innovation. For more information visit http://www.researchandmarkets.com/research/kl58bq/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
AdvanSource Biomaterials Completes $100,000 Short-Term Financing with Shareholders and Management
Business Wire - Tue Aug 27, 11:04AM CDT
AdvanSource Biomaterials Corporation (OTC Markets OTCQB: ASNB), a leading developer of advanced polymer materials for a broad range of medical devices, today announced the closing of a short-term debt financing transaction on August 22, 2013. The Company entered into Promissory Notes in the aggregate principal amount of $100,000 (the "Notes"